A new AI capability that delivers analysis-ready Media Intelligence. More than just a product launch, this is a shift in how communications teams monitor, understand and act on media coverage.
EU Public Affairs in Brussels. Healthcare and wellbeing enthusiast. Groningen alumni. Young Romanian Professional Abroad @mygraspbxl
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Alina
Contact Alina, search articles and posts on X, monitor coverage, and track replies from one place.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
INTRODUCTION Technological developments in medicines in areas of high unmet need have led to increased use of expedited regulatory pathways that bring medicines to market faster.1 This creates challenges for health technology assessment (HTA) bodies who must determine the added value of these new medicines while many uncertainties remain about their short or long-term consequences and optimal use outside the controlled setting of a clinical trial.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.